Huwe1, a novel cellular interactor of Gag-Pol through integrase binding, negatively influences HIV-1 infectivity

Microbes and Infection

Volumn 13, Issue 4, 2011, Pages 339-349

  Yamamoto, Seiji P ^a   Okawa, Katsuya ^a   Nakano, Takashi ^b   Sano, Kouichi ^b   Ogawa, Kanako ^c   Masuda, Takao ^d   Morikawa, Yuko ^e   Koyanagi, Yoshio ^a   Suzuki, Youichi ^c  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e KITASATO UNIVERSITY   (Japan)

Author keywords

Gag Pol precursor protein; HIV 1; Huwe1; Integrase; MoMLV

Indexed keywords

CELL PROTEIN; GAG PROTEIN; INTEGRASE; PROTEIN HUWE1; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME BINDING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS RELEASE; VIRUS REPLICATION;

ANIMALS; CELL LINE; FUSION PROTEINS, GAG-POL; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HELA CELLS; HIV INFECTIONS; HIV-1; HUMANS; INTEGRASES; MICE; MOLONEY MURINE LEUKEMIA VIRUS; NIH 3T3 CELLS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; UBIQUITIN-PROTEIN LIGASES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79952450408     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2010.12.002     Document Type: Article

References (45)

1. Lewinski M.K., Bushman F.D. Retroviral DNA integration-mechanism and consequences. Adv. Genet. 2005, 55:147-181.
2. Turlure F., Devroe E., Silver P.A., Engelman A. Human cell proteins and human immunodeficiency virus DNA integration. Front. Biosci. 2004, 9:3187-3208.
3. Swanstrom R., Wills J.W. Synthesis, Assembly, and Processing of Viral Proteins 1997, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
4. Wu X., Liu H., Xiao H., Conway J.A., Hunter E., Kappes J.C. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein. EMBO J. 1997, 16:5113-5122.
5. Shin C.G., Taddeo B., Haseltine W.A., Farnet C.M. Genetic analysis of the human immunodeficiency virus type 1 integrase protein. J. Virol. 1994, 68:1633-1642.
6. Engelman A., Englund G., Orenstein J.M., Martin M.A., Craigie R. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol. 1995, 69:2729-2736.
7. Masuda T., Planelles V., Krogstad P., Chen I.S. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain. J. Virol. 1995, 69:6687-6696.
8. Leavitt A.D., Robles G., Alesandro N., Varmus H.E. Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J. Virol. 1996, 70:721-728.
9. Bukovsky A., Gottlinger H. Lack of integrase can markedly affect human immunodeficiency virus type 1 particle production in the presence of an active viral protease. J. Virol. 1996, 70:6820-6825.
10. Tsurutani N., Kubo M., Maeda Y., Ohashi T., Yamamoto N., Kannagi M., Masuda T. Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells. J. Virol. 2000, 74:4795-4806.
11. Briones M.S., Dobard C.W., Chow S.A. Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core. J. Virol. 2010, 84:5181-5190.
12. Al-Mawsawi L.Q., Neamati N. Blocking interactions between HIV-1 integrase and cellular cofactors: an emerging anti-retroviral strategy. Trends Pharmacol. Sci. 2007, 28:526-535.
13. Studamire B., Goff S.P. Host proteins interacting with the Moloney murine leukemia virus integrase: multiple transcriptional regulators and chromatin binding factors. Retrovirology 2008, 5:48.
14. Hamamoto S., Nishitsuji H., Amagasa T., Kannagi M., Masuda T. Identification of a novel human immunodeficiency virus type 1 integrase interactor, Gemin2, that facilitates efficient viral cDNA synthesis in vivo. J. Virol. 2006, 80:5670-5677.
15. Mousnier A., Kubat N., Massias-Simon A., Segeral E., Rain J.C., Benarous R., Emiliani S., Dargemont C. von Hippel Lindau binding protein 1-mediated degradation of integrase affects HIV-1 gene expression at a postintegration step. Proc. Natl. Acad. Sci. U.S.A 2007, 104:13615-13620.
16. Yung E., Sorin M., Pal A., Craig E., Morozov A., Delattre O., Kappes J., Ott D., Kalpana G.V. Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1. Nat. Med. 2001, 7:920-926.
17. Christ F., Thys W., De Rijck J., Gijsbers R., Albanese A., Arosio D., Emiliani S., Rain J.C., Benarous R., Cereseto A., Debyser Z. Transportin-SR2 imports HIV into the nucleus. Curr. Biol. 2008, 18:1192-1202.
18. Woodward C.L., Prakobwanakit S., Mosessian S., Chow S.A. Integrase interacts with nucleoporin NUP153 to mediate the nuclear import of human immunodeficiency virus type 1. J. Virol. 2009, 83:6522-6533.
19. Sorin M., Yung E., Wu X., Kalpana G.V. HIV-1 replication in cell lines harboring INI1/hSNF5 mutations. Retrovirology 2006, 3:56.
20. Wei X., Decker J.M., Liu H., Zhang Z., Arani R.B., Kilby J.M., Saag M.S., Wu X., Shaw G.M., Kappes J.C. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 2002, 46:1896-1905.
21. Colicelli J., Goff S.P. Sequence and spacing requirements of a retrovirus integration site. J. Mol. Biol. 1988, 199:47-59.
22. Burckstummer T., Bennett K.L., Preradovic A., Schutze G., Hantschel O., Superti-Furga G., Bauch A. An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells. Nat. Methods 2006, 3:1013-1019.
23. Nishitsuji H., Hayashi T., Takahashi T., Miyano M., Kannagi M., Masuda T. Augmentation of reverse transcription by integrase through an interaction with host factor, SIP1/Gemin2 Is critical for HIV-1 infection. PLoS One 2009, 4:e7825.
24. Jensen O.N., Podtelejnikov A., Mann M. Delayed extraction improves specificity in database searches by matrix-assisted laser desorption/ionization peptide maps. Rapid Commun. Mass Spectrom. 1996, 10:1371-1378.
25. Shinoda Y., Hieda K., Koyanagi Y., Suzuki Y. Efficient transduction of cytotoxic and anti-HIV-1 genes by a gene-regulatable lentiviral vector. Virus Genes 2009, 39:165-175.
26. Niwano K., Arai M., Koitabashi N., Watanabe A., Ikeda Y., Miyoshi H., Kurabayashi M. Lentiviral vector-mediated SERCA2 gene transfer protects against heart failure and left ventricular remodeling after myocardial infarction in rats. Mol. Ther. 2008, 16:1026-1032.
27. Sato K., Aoki J., Misawa N., Daikoku E., Sano K., Tanaka Y., Koyanagi Y. Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins. J. Virol. 2008, 82:1021-1033.
28. Kawano Y., Tanaka Y., Misawa N., Tanaka R., Kira J.I., Kimura T., Fukushi M., Sano K., Goto T., Nakai M., Kobayashi T., Yamamoto N., Koyanagi Y. Mutational analysis of human immunodeficiency virus type 1 (HIV-1) accessory genes: requirement of a site in the nef gene for HIV-1 replication in activated CD4+ T cells in vitro and in vivo. J. Virol. 1997, 71:8456-8466.
29. Zack J.A., Arrigo S.J., Weitsman S.R., Go A.S., Haislip A., Chen I.S. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990, 61:213-222.
30. Neil S.J., Zang T., Bieniasz P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-430.
31. Suzuki Y., Misawa N., Sato C., Ebina H., Masuda T., Yamamoto N., Koyanagi Y. Quantitative analysis of human immunodeficiency virus type 1 DNA dynamics by real-time PCR: integration efficiency in stimulated and unstimulated peripheral blood mononuclear cells. Virus Genes 2003, 27:177-188.
32. Huang M., Orenstein J.M., Martin M.A., Freed E.O. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 1995, 69:6810-6818.
33. Bernassola F., Karin M., Ciechanover A., Melino G. The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell 2008, 14:10-21.
34. Chen D., Kon N., Li M., Zhang W., Qin J., Gu W. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell 2005, 121:1071-1083.
35. Zhong Q., Gao W., Du F., Wang X. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 2005, 121:1085-1095.
36. Wade R.H., Hyman A.A. Microtubule structure and dynamics. Curr. Opin. Cell Biol. 1997, 9:12-17.
37. Naghavi M.H., Goff S.P. Retroviral proteins that interact with the host cell cytoskeleton. Curr. Opin. Immunol. 2007, 19:402-407.
38. de Soultrait V.R., Caumont A., Durrens P., Calmels C., Parissi V., Recordon P., Bon E., Desjobert C., Tarrago-Litvak L., Fournier M. HIV-1 integrase interacts with yeast microtubule-associated proteins. Biochim. Biophys. Acta 2002, 1575:40-48.
39. Ono A. Relationships between plasma membrane microdomains and HIV-1 assembly. Biol. Cell 2010, 102:335-350.
40. Halwani R., Khorchid A., Cen S., Kleiman L. Rapid localization of Gag/GagPol complexes to detergent-resistant membrane during the assembly of human immunodeficiency virus type 1. J. Virol. 2003, 77:3973-3984.
41. Simons K., Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 2000, 1:31-39.
42. Yung E., Sorin M., Wang E.J., Perumal S., Ott D., Kalpana G.V. Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significance. J. Virol. 2004, 78:2222-2231.
43. Sorin M., Cano J., Das S., Mathew S., Wu X., Davies K.P., Shi X., Cheng S.W., Ott D., Kalpana G.V. Recruitment of a SAP18-HDAC1 complex into HIV-1 virions and its requirement for viral replication. PLoS Pathog. 2009, 5:e1000463.
44. Izumi T., Takaori-Kondo A., Shirakawa K., Higashitsuji H., Itoh K., Io K., Matsui M., Iwai K., Kondoh H., Sato T., Tomonaga M., Ikeda S., Akari H., Koyanagi Y., Fujita J., Uchiyama T. MDM2 is a novel E3 ligase for HIV-1 Vif. Retrovirology 2009, 6:1.
45. Brass A.L., Dykxhoorn D.M., Benita Y., Yan N., Engelman A., Xavier R.J., Lieberman J., Elledge S.J. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319:921-926.